Walgreens Boots 4Q Adj. EPS Beats, Now Sees RAD Close Early ’17
Source: BFW (Bloomberg First Word)
Tickers
WBA US (Walgreens Boots Alliance Inc)
To de-activate this alert, click here
UUID: 7947283
(Bloomberg) -- Walgreens Boots sees FY17 adj. EPS $4.85-$5.20, est. $5.01 (range $4.81-$5.20).
Alert: HALISTER- Forecast assumes 5c-12c gain from Rite Aid
- Now sees RAD deal closing in early 2017, expects to be able to execute agreements to divest stores by end of 2016
- Remains engaged with FTC regarding its review, still sees required divestitures of 500-1,000 stores as most likely outcome
- 4Q adj. EPS $1.07, est. 99c
- 4Q revenue $28.6b, est. $29.07b
- 4Q Retail Pharmacy USA comp. sales rose 3.2% y/y
- Comp. pharmacy sales up 5% y/y, comp. retail sales down 0.3%
- Conf. call 8:30am; see webcast link, or listen on LIVE
- Analysts were cautious on FY17 forecast; see earnings preview
Source: BFW (Bloomberg First Word)
Tickers
WBA US (Walgreens Boots Alliance Inc)
To de-activate this alert, click here
UUID: 7947283